TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients

Gene

Volumn 527, Issue 1, 2013, Pages 211-214

  El Karaksy, Safaa Mostafa ^a   Kholoussi, Naglaa Mohamed ^b   Shahin, Rasha Mohamad Hosny ^a   El Ghar, Mona Mohsen Abou ^b   Gheith, Rasha El Sayed ^a  

^a Cairo University   (Egypt)

^b National Research Institute   (Egypt)

Author keywords

Real time reverse transcription polymerase chain reaction; Systemic lupus erythematosus; Tumor necrosis factor related apoptosis inducing ligand (TRAIL)

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84881260152     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.05.084     Document Type: Article

References (19)

1. Bennett L., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003, 197(6):711-723.
2. Cassatella M.A. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils. Leukoc. Biol. 2006, 79(6):1140-1149.
3. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
4. Kaplan M.J. Apoptosis in systemic lupus erythematosus. Clin. Immunol. 2004, 112(3):210-218.
5. Kaplan M.J., et al. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J. Immunol. 2002, 169(10):6020-6029. (15).
6. Komatsuda A., et al. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus. Clin. Immunol. 2007, 125(1):26-29.
7. Liabakk N., Sundan A., Torp S., Aukrust P., Froland S., Espevik T. Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. J. Immunol. Methods 2002, 259:119-128.
8. Lub-de Hooge M.N., de Vries E.G., de Jong S., Bijl M. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2005, 64(6):854-858.
9. Nguyen V., et al. TRAIL, DR4 and DR5 are up-regulated in kidneys from patients with lupus nephritis and exert proliferative and pro-inflammatory effects. Clin. Immunol. 2009, 132(1):32-42.
10. Nomura S., et al. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation. Transpl. Immunol. 2007, 18(2):115-121.
11. Okuyama S., et al. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephritic syndrome. Nephrol. Dial. Transplant. 2005, 20:539-544.
12. Ren Y., Tang J., Mok M.Y., Chan A.W., Wu A., Lau C.S. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 2003, 48(10):2888-2897.
13. Rus V., et al. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin. Immunol. 2002, 102(3):283-290.
14. Rus V., Zernetkina V., Puliaev R., Cudrici C., Mathai S., Via C.S. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Clin. Immunol. 2005, 117(1):48-56.
15. Tan E.M., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
16. Truneh A., et al. Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor. J. Biol. Chem. 2000, 275:23319-23325.
17. Wei W., Liu Y., Zheng D. Current understanding on the immunological functions of tumor necrosis factor-related apoptosis-inducing ligand. Cell. Mol. Immunol. 2005, 2(4):265-269.
18. White S., Rosen A. Apoptosis in systemic lupus erythematosus. Curr. Opin. Rheumatol. 2003, 15(5):557-562.
19. Zahn S., Rehkämper C., Ferring-Schmitt S., Bieber T., Tüting T., Wenzel J. Interferon-α stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus. Br. J. Dermatol. 2011, 165(5):1118-1123.